J&J Shot Loses Antibody Protection Against Omicron In Study - NDTV
Johnson & Johnson's vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain's ability to get around one pillar of the body's defenses.
Johnson & Johnson's antibody protection looking particularly weak in the lab test.
Johnson & Johnson's vaccine produced virtually no antibody protection against the omicron coronavirus varia… [+3140 chars]
Read More
Other Stories in Health
- White wine vs. red wine: Which poses a greater cancer risk?
- Better heart health slows brain aging and lowers dementia risk, study finds
- 8 foods to keep your kidneys healthy
- Rekha redefines power dressing in a stunning white pantsuit at trailer launch
- Can applying sunscreen regularly cause vitamin D deficiency?
- Groundbreaking vaccine study offers hope for ending meningitis in Africa
- Ovarian cancer mutations across populations show similarities and unique differences
- Health-care workers should not be a target. In Gaza, their detention and death affect the entire population
- 7 most cancer-causing things present in our home
.png)
